IP Library Granted Patent US 8,642,783
Granted Patent B2
US 8,642,783 · App. 12/671,752 · Granted Feb 4, 2014

Process for preparing chiral compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,642,783
App. No.
12/671,752
Granted
Feb 4, 2014
Kind
B2
Abstract

The present invention is directed to a 2-deoxyribose-5-phosphate aldolase (DERA) chemoenzymatic process for making chiral compounds.

Claims (21)

1. A process comprising the step of reacting acetaldehyde with an N-protected aminoaldehyde substrate selected from the group consisting of 3-phthalimidopropionaldehyde, and 3-succinimidopropionaldehyde under aldolase-catalyzed aldol condensation conditions to form the corresponding lactol.

2. The process according to claim 1 , wherein said aldolase is a 2-deoxyribose-5-phosphate aldolase (DERA) aldolase.

3. The process according to claim 2 , wherein said aldolase is DERA 04 comprising a nucleotide sequence of SEQ ID No. 2 or an amino acid sequence of SEQ ID No. 17;

DERA 06 comprising a nucleotide sequence of SEQ ID No. 3 or an amino acid sequence of SEQ ID No. 18;

DERA 101 comprising a nucleotide sequence of SEQ ID No. 8 or an amino acid sequence of SEQ ID No. 23;

DERA 102 comprising a nucleotide sequence of SEQ ID No. 9 or an amino acid sequence of SEQ ID No. 24;

DERA 103 comprising a nucleotide sequence of SEQ ID No. 10 or an amino acid sequence of SEQ ID No. 25;

DERA 104 comprising a nucleotide sequence of SEQ ID No. 11 or an amino acid sequence of SEQ ID No. 26;

DERA 105 comprising a nucleotide sequence of SEQ ID No. 12 or an amino acid sequence of SEQ ID No. 27;

DERA 106 comprising a nucleotide sequence of SEQ ID No. 13 or an amino acid sequence of SEQ ID No. 28;

DERA 107 comprising a nucleotide sequence of SEQ ID No. 14 or an amino acid sequence of SEQ ID No. 29;

DERA 108 comprising a nucleotide sequence of SEQ ID No. 15 or an amino acid sequence of SEQ ID No. 30;

or an aldolase having an amino acid sequence identity of at least about 20% thereof.

4. The process of claim 2 , wherein said aldolase is DERA 04 comprising a nucleotide sequence of SEQ ID No. 2 or an amino acid sequence of SEQ ID No.17; DERA 06 comprising a nucleotide sequence of SEQ ID No. 3 or an amino acid sequence of SEQ ID No. 18; DERA 102 comprising a nucleotide sequence of SEQ ID No. 9 or an amino acid sequence of SEQ ID No. 24.

5. The process according to claim 2 , wherein said aldolase is DERA 04 comprising a nucleotide sequence of SEQ ID No. 2 or an amino acid sequence of SEQ ID No. 17.

6. The process according to claim 2 , wherein said aldolase is DERA 102 comprising a nucleotide sequence of SEQ ID No. 9 or an amino acid sequence of SEQ ID No. 24.

7. The process according to claim 1 , wherein said N-protected aminoaldehyde substrate is 3-phthalimidopropionaldehyde.

8. The process according to claim 1 , wherein said N-protected aminoaldehyde substrate is 3-succinimido-propionaldehyde.

9. The process according to claim 1 , further including oxidizing the lactol so formed to yield the corresponding lactone.

10. The process according to claim 9 , further including reacting the lactone so formed with isopropyl alcohol and acetone to yield the corresponding isopropyl acetonide ester.

11. The process according to claim 9 , further including reacting the lactone so formed with cyclopentanone and isopropyl alcohol to yield the corresponding cyclopentylidene phthalimido isopropyl ester.

Assignments (2)
CHANGE OF NAME Recorded Oct 31, 2022
From: UPJOHN US 1 LLC
To: VIATRIS SPECIALTY LLC.
Reel/Frame 061808/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: PFIZER INC.
To: UPJOHN US 1 LLC
Reel/Frame 054293/0154 →